When you were first diagnosed, your doctor may have told you that most new HPV infections of the cervix clear on their own within 2 years. However, for some women, the infection doesn’t go away.
Because your infection has not yet cleared, it is considered a persistent HPV infection. You may want to consider joining other women in a research study for persistent HPV infections.
In this study, doctors are evaluating three investigational therapeutic vaccines for women who have been diagnosed with persistent HPV16 or HPV18 infection. The investigational vaccines will be compared to placebo, which looks like the investigational vaccines, but is not an active vaccine.
The investigational vaccines have not been approved to treat persistent HPV infections. They are considered under investigation and are only available in research studies like this one.
Who is eligible to participate in this study?
To pre-qualify for this study, you must:
- Be a woman who is 18 to 60 years of age
- Have been diagnosed with persistent HPV16 or HPV18 infection of the cervix for at least 12 months
- Not have a diagnosis of both HPV16 and HPV18
All study-required visits, tests, and investigational vaccines will be provided at no cost. In addition, reimbursement for study-required travel will be provided.
To learn more, call our Newton location at 316-283-0828
Please fill out your information below and a Heartland Research specialist will contact you with more information for this study.
The information you provide is entered in our secure, password protected database. The provided information will only be used to contact you to tell you more about the study. You have the choice to have your information saved or removed from our records. If you elect to have contact information saved within our database, it will remain indefinitely. To be removed please call a Heartland Research specialist at 316-689-6626 or email email@example.com.